サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588735

グルコースバイオセンサーの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Glucose Biosensors Market Size, Share & Trends Analysis Report By Type (Electrochemical Biosensors, Optical Biosensors), By End Use (Hospitals, Homecare, Diagnostic Centers), By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 190 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
グルコースバイオセンサーの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月28日
発行: Grand View Research
ページ情報: 英文 190 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

グルコースバイオセンサー市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、グルコースバイオセンサーの世界市場規模は、2025年から2030年にかけてCAGR 8.5％を記録し、2030年には156億8,000万米ドルに達する見込みです。

グルコースバイオセンサーは、糖尿病患者の血糖濃度モニタリングを支援するグルコースモニタリングシステムの不可欠な部分であり、ひいては糖尿病の管理と制御、さらなる合併症の回避に役立ちます。国際糖尿病連合は、2021年には5億3,700万人が糖尿病と診断され、その数は2045年には7億8,300万人に達すると予測しています。

グルコースモニタリングにおける新たな技術革新が市場を拡大しています。汗、血液、唾液、涙などさまざまな体液を利用し、校正が可能なグルコースバイオセンサーの研究が進んでいます。例えば、2021年10月、ペンシルベニア州立大学の研究者は、血液ではなく汗中のグルコースを評価できる新規技術を発明し、これにより針を刺す必要性をなくしました。

市場の著名な競合他社は、製品ポートフォリオを拡大し、製造能力を強化するために、中堅・中小企業への資金提供や買収など、さまざまな取り組みを行っています。例えば、2020年8月、Senseonics HoldingsはPHC Holdings CorporationおよびAscensia Diabetes Careと戦略的パートナーシップを締結しました。これにより、AscensiaはSenseonicsのCGMシステムの世界の独占販売パートナーとなった。

グルコースバイオセンサー市場レポートハイライト

  • タイプ別では、電気化学バイオセンサセグメントが、その感度、再現性、メンテナンスの容易さにより、2024年に最大の収益シェアを占めました。
  • グルコースバイオセンサーが病院環境で広く使用されていること、糖尿病で病院を訪れる患者数が増加していることから、病院の最終用途セグメントが2024年に最大の収益シェアを占めました。
  • 北米は、2024年に最大の収益シェアを占めました。アジア太平洋は、ヘルスケア施設と償還政策の改善により、予測期間中に最も速いCAGRで拡大すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 グルコースバイオセンサー市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • グルコースバイオセンサー市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 グルコースバイオセンサー市場：タイプの推定・動向分析

  • セグメントダッシュボード
  • グルコースバイオセンサー市場：タイプ変動分析
  • グルコースバイオセンサー市場：タイプ別展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 電気化学バイオセンサー
  • 光学バイオセンサー
  • その他

第5章 グルコースバイオセンサー市場：最終用途の推定・動向分析

  • セグメントダッシュボード
  • グルコースバイオセンサー市場：最終用途変動分析
  • 最終用途別グルコースバイオセンサー市場展望
  • 2018年から2030年までの市場規模と予測および動向分析
  • 病院
  • ホームケア
  • 診断センター

第6章 グルコースバイオセンサー市場：地域の推定・動向分析

  • 地域ダッシュボード
  • 地域別グルコースバイオセンサー市場変動分析
  • グルコースバイオセンサー市場：技術と最終用途別の地域推定・動向分析
  • 2018年から2030年までの市場規模と予測および動向分析
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 市場参入企業の分類
  • 主要企業プロファイル
    • Abbott.
    • Dexcom Inc.
    • Ascensia Diabetes Care Holdings AG.
    • Nova Diabetes Care
    • F. Hoffmann-La Roche AG
    • Sanofi
    • GlySens Incorporated
    • Trividia Health, Inc.
    • Bayer AG
    • LifeScan IP Holdings,
    • PalmSens
    • Biolinq Incorporated.
    • SB Solutions
    • Nutrix AG
図表

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 4. Global glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 5. North America glucose biosensors market, by region, 2018 - 2030 (USD Million)
  • Table 6. North America glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 7. North America glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 8. U.S. glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 9. U.S. glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Canada glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 11. Canada glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Europe glucose biosensors market, by country, 2018 - 2030 (USD Million)
  • Table 13. Europe glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 14. Europe glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 15. UK glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 16. UK glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 18. Germany glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 19. France glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 20. France glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Italy glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 22. Italy glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Spain glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 24. Spain glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Norway glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 26. Norway glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Sweden glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 28. Sweden glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Denmark glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 30. Denmark glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Asia Pacific glucose biosensors market, by country, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 34. Japan glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 35. Japan glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 36. China glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 37. China glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 38. India glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 39. India glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Australia glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 41. Australia glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 43. South Korea glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Thailand glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 45. Thailand glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Latin America glucose biosensors market, by country, 2018 - 2030 (USD Million)
  • Table 47. Latin America glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 48. Latin America glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Brazil glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 50. Brazil glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Mexico glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 52. Mexico glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Argentina glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 54. Argentina glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa glucose biosensors market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 59. South Africa glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 63. UAE glucose biosensors market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait glucose biosensors market, by type, 2018 - 2030 (USD Million)
  • Table 65. Kuwait glucose biosensors market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Glucose Biosensors market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Glucose biosensors market, type outlook key takeaways (USD Million)
  • Fig. 12 Glucose biosensors market: type movement analysis 2024 & 2030 (USD Million)
  • Fig. 13 Electrochemical biosensor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Optical biosensor market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Glucose biosensors market, end use outlook key takeaways (USD Million)
  • Fig. 17 Glucose biosensors market: end use movement analysis 2024 & 2030 (USD Million)
  • Fig. 18 Hospitals market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Homecare market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Diagnostic centers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Glucose biosensors market: Regional key takeaways (USD Million)
  • Fig. 22 Glucose biosensors market: regional outlook, 2024 & 2030 (USD Million)
  • Fig. 23 North America glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 U.S. glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Canada glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Europe glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 UK glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Germany glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 France glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Spain glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Italy glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Sweden glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Norway glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Denmark glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Asia Pacific glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 China glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Japan glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 India glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 South Korea glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Australia glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Thailand glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Latin America glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Brazil glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Mexico glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Argentina glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Middle East and Africa glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 South Africa glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Saudi Arabia glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 UAE glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Kuwait glucose biosensors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 List of key emerging company's/technology disruptors/innovators
目次
Product Code: 978-1-68038-739-1

Glucose Biosensors Market Growth & Trends:

The global glucose biosensors market size is expected to reach USD 15.68 billion by 2030, registering a CAGR of 8.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. Glucose biosensors are an essential part of glucose monitoring systems that aid in monitoring blood glucose concentration in diabetic patients, which, in turn, helps them to manage and control diabetes and avoid any further complications. The International Diabetes Federation stated that in 2021, 537 million people were diagnosed with diabetes, and the number is anticipated to reach 783 million by 2045.

Emerging innovations in glucose monitoring are expanding the market. Glucose biosensors that use different body fluids such as sweat, blood, saliva, and tear and can be calibrated, are being increasingly researched. For instance, in October 2021, Penn State University researchers invented a novel technique that can assess glucose in sweat rather than blood, thus removing the need for a needle prick.

The market's prominent competitors are taking different initiatives such as funding and acquisitions of medium and small-sized businesses, in order to expand their product portfolio and enhance their manufacturing capacity. For instance, in August 2020, Senseonics Holdings entered into a strategic partnership with PHC Holdings Corporation and Ascensia Diabetes Care. This allowed Ascensia to be the exclusive global distribution partner for Senseonics' CGM systems.

Glucose Biosensors Market Report Highlights:

  • By type, the electrochemical biosensor segment accounted for the largest revenue share in 2024 owing to its sensitivity, reproducibility, and ease of maintenance
  • The hospital end-use segment held the largest revenue share in 2024, owing to the extensive use of glucose biosensors in hospital settings and an increase in the number of patients visiting hospitals with diabetes.
  • North America accounted for the largest revenue share in 2024. Asia Pacific is anticipated to expand at the fastest CAGR during the forecast period, owing to the improved healthcare facilities and reimbursement policies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. End Use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Glucose Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing incidence of diabetes
      • 3.2.1.2. Rising demand for minimally and small sized glucose monitoring devices
      • 3.2.1.3. Growing patient awareness
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Presence of alternative method
  • 3.3. Glucose Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Glucose Biosensors Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Glucose Biosensors Market: Type Movement Analysis
  • 4.3. Glucose Biosensors Market by Type Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Electrochemical Biosensor
    • 4.5.1. Electrochemical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Optical Biosensor
    • 4.6.1. Optical Biosensor Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Glucose Biosensors Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Glucose Biosensors Market: End Use Movement Analysis
  • 5.3. Glucose Biosensors Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Hospitals
    • 5.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Homecare
    • 5.6.1. Homecare Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Diagnostic Centers
    • 5.7.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Glucose Biosensors Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Glucose Biosensors Market Movement Analysis
  • 6.3. Glucose Biosensors Market: Regional Estimates & Trend Analysis by Technology & End-use
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. UK Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. Germany Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. France Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. Italy Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Spain Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Denmark
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Denmark Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Competitive Scenario
      • 6.6.8.3. Regulatory Framework
      • 6.6.8.4. Reimbursement scenario
      • 6.6.8.5. Sweden Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.9. Norway
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Competitive Scenario
      • 6.6.9.3. Regulatory Framework
      • 6.6.9.4. Reimbursement scenario
      • 6.6.9.5. Norway Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Asia Pacific Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Japan
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Japan Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. China
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. China Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. India
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. India Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Regulatory Framework
      • 6.7.5.4. Reimbursement scenario
      • 6.7.5.5. South Korea Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.6. Australia
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Competitive Scenario
      • 6.7.6.3. Regulatory Framework
      • 6.7.6.4. Reimbursement scenario
      • 6.7.6.5. Australia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.7. Thailand
      • 6.7.7.1. Key Country Dynamics
      • 6.7.7.2. Competitive Scenario
      • 6.7.7.3. Regulatory Framework
      • 6.7.7.4. Reimbursement scenario
      • 6.7.7.5. Thailand Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Latin America Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. Brazil
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. Brazil Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Mexico
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Mexico Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. Argentina
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. Argentina Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.9. Middle East & Africa
    • 6.9.1. Middle East & Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.2. South Africa
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Competitive Scenario
      • 6.9.2.3. Regulatory Framework
      • 6.9.2.4. Reimbursement scenario
      • 6.9.2.5. South Africa Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.3. Saudi Arabia
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Competitive Scenario
      • 6.9.3.3. Regulatory Framework
      • 6.9.3.4. Reimbursement scenario
      • 6.9.3.5. Saudi Arabia Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.9.4.2. Competitive Scenario
      • 6.9.4.3. Regulatory Framework
      • 6.9.4.4. Reimbursement scenario
      • 6.9.4.5. UAE Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.9.5. Kuwait
      • 6.9.5.1. Key Country Dynamics
      • 6.9.5.2. Competitive Scenario
      • 6.9.5.3. Regulatory Framework
      • 6.9.5.4. Reimbursement scenario
      • 6.9.5.5. Kuwait Glucose Biosensors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Abbott.
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Dexcom Inc.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Ascensia Diabetes Care Holdings AG.
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Nova Diabetes Care
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. F. Hoffmann-La Roche AG
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Sanofi
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. GlySens Incorporated
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Trividia Health, Inc.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Bayer AG
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. LifeScan IP Holdings,
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. PalmSens
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Biolinq Incorporated.
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. SB Solutions
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Nutrix AG
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives